Humanigen Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Humanigen Inc
CIK #0001293310
EDGAR Form CIK 2011 - 2026
10-K [0001293310]
10-Q [0001293310]
3 [0001293310]
4 [0001293310]
5 [0001293310]
8-K [0001293310]
D [0001293310]
SC 13D [0001293310]
SC 13G [0001293310]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Humanigen Inc [2022-05-09]
BlackRock Inc Humanigen Inc [2022-02-04]
Murchinson Ltd Humanigen Inc [2021-12-30]
State Street Corp Humanigen Inc [2021-10-12]
Valiant Capital Management LP Humanigen Inc [2020-06-12]
Venrock Healthcare Capital Partners II LP Humanigen Inc [2020-06-12]
Nantahala Capital Management LLC Kalobios Pharmaceuticals Inc [2017-02-14]
DHAR Kapil Kalobios Pharmaceuticals Inc [2016-08-16]
Nomis Bay Ltd Kalobios Pharmaceuticals Inc [2016-07-13]
Black Horse Capital LP Kalobios Pharmaceuticals Inc [2016-07-11]
View All
Form 3/4/5 Subject 2011 - 2026
Cheval Holdings Ltd
Humanigen Inc
Black Horse Capital Management LLC
Black Horse Capital Master Fund Ltd
Chappell Dale
Black Horse Capital LP
Buxton Cheryl
Xie Yili Kevin
Durrant Cameron
Kilcoyne Adrian
Hohneker John
Barliant Ronald
Boehm Rainer J
Jordan Edward P
Morris Timothy E
Nomis Bay Ltd
Tousley David L
Savage Robert G
Jester J Gregory
Lam Morgan
Friedberg Ezra M
Shkreli Martin
Witter Dean III
Harrison Michael Wayne
Fernandez Thomas Edward
Biestek Marek
Anthion Partners II LLC
Moradi David
Chase Anthony R
Cross Herb
Martell Ron
Baffi Robert
Gilbert Denise
Love Ted W
Lyons Gary A
Smaldone Alsup Laurie
Withy Raymond M
Joseph Donald
Yarranton Geoffrey Thomas
Lawlis V Bryan
Pritchard David
Molfino Nestor
Smith Brigitte
Henner Dennis
Healy James
Cooper Jeffrey H
5AM Partners LLC
Development Bank of Japan Inc
Mitsubishi UFJ Capital II Limited Partnership
Baxter International Inc
Genesis Fund
GBS BioVentures II A/C
GBS Venture Partners Pty Ltd
Alloy Corporate 2000 LP
Alloy Investors 2000 LP
Alloy Annex I LP
Alloy Ventures 2000 LLC
Alloy Partners 2000 LP
Alloy Ventures 2000 LP
Alloy Annex I LLC
Azan Alain
Sofinnova Management V 2005 LLC
Sofinnova Management V LLC
Sofinnova Venture Partners V LP
Powell Michael
Sofinnova Venture Affiliates V LP
Sofinnova Venture Principals V LP
Lehman Brothers Holdings Inc
EDB Investments Pte Ltd
Singapore Bio Innovations PTE Ltd
Sanofi
MPM BioVentures III LLC
MPM Asset Management Investors 2005 BVIII LLC
MPM BioVentures Strategic Fund LP
MPM BioVentures III GP LP
MPM BioVentures III Parallel Fund LP
MPM BioVentures III LP
MPM BioVentures III GmbH & CO Beteiligungs KG
MPM BioVentures III-QP LP
Evnin Luke
Galakatos Nicholas
Wheeler Kurt
Gadicke Ansbert
Simon Nicholas J III
Steinmetz Michael
5AM Ventures LLC
5AM Co Investors LLC
Shochat Dan
Lehman Brothers Holdings Inc Plan Trust
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Humanigen Inc HGEN
Common Stock, $0.001 par value
2023-10-18 Sell 34,253 $0.01 343
Humanigen Inc HGEN
Common Stock, $0.001 par value
2023-10-18 Sell 276,210 $0.01 2,762
Humanigen Inc HGEN
Common Stock, $0.001 par value
2023-10-18 Sell 75,887 $0.01 759
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 83,418 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 55,612 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 808,906 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 73,307 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 78,362 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 518,205 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 537,164 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 600,360 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 63,195 $0.00
Humanigen Inc HGEN
Stock Option (Right to Buy) · derivative
2022-07-27 Grant 455,010 $0.00
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-20 Buy 54,549 $2.23 121,644
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-20 Buy 109,098 $2.23 243,289
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-20 Buy 381,841 $2.23 851,505
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-19 Buy 64,762 $2.19 141,829
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-19 Buy 226,665 $2.19 496,396
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-19 Buy 32,381 $2.19 70,914
Humanigen Inc HGEN
Common Stock, $0.001 par value
2022-05-18 Buy 34,740 $1.96 68,090
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com